Cargando…
Pro108Ser mutation of SARS-CoV-2 3CL(pro) reduces the enzyme activity and ameliorates the clinical severity of COVID-19
Recently, an international randomized controlled clinical trial showed that patients with SARS-CoV-2 infection treated orally with the 3-chymotrypsin-like protease (3CL(pro)) inhibitor PF-07321332 within three days of symptom onset showed an 89% lower risk of COVID-19-related hospital admission/ dea...
Autores principales: | Abe, Kodai, Kabe, Yasuaki, Uchiyama, Susumu, Iwasaki, Yuka W., Ishizu, Hirotsugu, Uwamino, Yoshifumi, Takenouchi, Toshiki, Uno, Shunsuke, Ishii, Makoto, Maruno, Takahiro, Noda, Masanori, Murata, Mitsuru, Hasegawa, Naoki, Saya, Hideyuki, Kitagawa, Yuko, Fukunaga, Koichi, Amagai, Masayuki, Siomi, Haruhiko, Suematsu, Makoto, Kosaki, Kenjiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789791/ https://www.ncbi.nlm.nih.gov/pubmed/35079088 http://dx.doi.org/10.1038/s41598-022-05424-3 |
Ejemplares similares
-
Clinical utility of SARS-CoV-2 whole genome sequencing in deciphering source of infection
por: Takenouchi, T., et al.
Publicado: (2021) -
Ketogenic diet in action: Metabolic profiling of pyruvate dehydrogenase deficiency
por: Ogawa, Eri, et al.
Publicado: (2023) -
Multiple introductions of SARS-CoV-2 B.1.1.214 lineages from mainland Japan preceded the third wave of the COVID-19 epidemic in Hokkaido
por: Shimura, Takako, et al.
Publicado: (2021) -
Function and structural regulation of the carbon monoxide (CO)-responsive membrane protein PGRMC1
por: Kabe, Yasuaki, et al.
Publicado: (2018) -
Mutation of PTPN11 (Encoding SHP-2) Promotes MEK Activation and Malignant Progression in Neurofibromin-Deficient Cells in a Manner Sensitive to BRAP Mutation
por: Harigai, Ritsuko, et al.
Publicado: (2022)